 Long-term remission chronic hepatitis alpha-interferon therapy OBJECTIVE remissions chronic hepatitis alpha-interferon therapy long duration DESIGN Cohort study SETTING Clinical Center National Health tertiary referral center PATIENTS Sixty-four patients chronic hepatitis alpha-interferon MAIN OUTCOME MEASURES Patients frequent examinations determinations serum liver biochemical tests hepatitis virus HBV markers hepatitis surface antigen HBsAg hepatitis antigen HBeAg HBV DNA blot hybridization polymerase chain reaction RESULTS patients chronic hepatitis alpha-interferon treatment loss HBeAg improvement serum aminotransferases years mean years follow-up patients reappearance HBeAg abnormal serum aminotransferases year therapy patients detectable HBeAg HBV DNA blot hybridization serum asymptomatic liver disease minimal elevations serum aminotransferases Thirteen patients negative HBsAg years mean years loss HBeAg patient HBV DNA detectable blot hybridization patients HBsAg positive HBV DNA serum polymerase chain reaction HBsAg-negative patients viral genome method sequential samples HBV DNA polymerase chain reaction time test results HBsAg negative CONCLUSIONS Remissions chronic hepatitis alpha-interferon long duration patients loss HBsAg evidence residual virus replication